A good report card, but there is room for improving care for patients with myocardial infarction

John K French
Med J Aust 2021; 214 (11): . || doi: 10.5694/mja2.51110
Published online: 21 June 2021

Improving systems of care can achieve earlier treatment and increase survival

The report by Nadlacki and colleagues1 on long term outcomes for patients after myocardial infarction provides much needed clarity about progress in care in Australia and New Zealand during 2009‒2015. The next step, well overdue, is a prospective, comprehensive registry based on the current universal definition of myocardial infarction,2 rather than on information derived from administrative data using International Classification of Diseases (ICD) codes. The major advances in terms of technology, pharmacology, and patterns of care for people with myocardial infarction in Australia and New Zealand should not lead to complacency; improvements are still required, at both the systems and local levels, to achieve good quality care for all. For this we need outcomes data for unselected patients with myocardial infarction, as has been collected in New Zealand for almost a decade (ANZACS‐QI)3 and in Sweden for more than two decades (the SWEDEHEART registry).4

  • 1 Liverpool Hospital, Sydney, NSW
  • 2 Ingham Institute for Applied Medical Research, Western Sydney University, Sydney, NSW
  • 3 University of New South Wales, Sydney, NSW


Competing interests:

No relevant disclosures.

  • 1. Nadlacki B, Horton D, Hossain S, et al. Long term survival after acute myocardial infarction in Australia and New Zealand, 2009–2015: a population cohort study. Med J Aust 2021; 214: 519–525.
  • 2. Thygesen K, Alpert JS, Jaffe AS, et al; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019; 40: 237–269.
  • 3. Kerr A, Williams MJ, White H, et al. The all New Zealand acute coronary syndrome quality improvement programme: implementation, methodology and cohorts (ANZACS‐QI 9). N Z Med J 2016; 129: 23–36.
  • 4. Melki D, Lugnegård J, Alfredsson J, et al. Implications of introducing high‐sensitivity cardiac troponin T into clinical practice: data from the SWEDEHEART Registry. J Am Coll Cardiol 2015; 65: 1655–1664.
  • 5. Etaher A, Gibbs OJ, Saad YM, et al. Type‐II myocardial infarction and chronic myocardial injury rates, invasive management, and 4‐year mortality among consecutive patients undergoing high‐sensitivity troponin T testing in the emergency department. Eur Heart J Qual Care Clin Outcomes 2020; 6: 41–48.
  • 6. Lambrakis K, French JK, Scott IA, et al. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT‐2): a randomized trial design. Am Heart J 2019; 208: 11–20.
  • 7. Etaher A, Chew DP, Frost S, et al. Prognostic implications of high sensitivity Troponin T levels among patients attending emergency departments and evaluated for an acute coronary syndrome. Am J Med 2021; [online ahead of print].
  • 8. Aliprandi‐Costa B, Ranasinghe I, Turnbull F, et al. The design and rationale of the Australian cooperative National Registry of acute coronary care, guideline adherence and clinical events (CONCORDANCE). Heart Lung Circ 2013; 22: 533–541.
  • 9. Brieger DB, Chew D, Redfern J, et al. Survival after an acute coronary syndrome: 18‐month outcomes from the Australian and New Zealand SNAPSHOT ACS Study. Med J Aust 2015; 203: 368.
  • 10. Chew DP, Scott IA, Cullen L, et al; NHFA/CSANZ ACS Guideline 2016 Executive Working Group. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart Lung Circ 2016; 25: 895–951.
  • 11. Burgess SN, French JK, Nguyen TL, et al. The impact of incomplete revascularization on early and late outcomes in ST‐elevation myocardial infarction. Am Heart J 2018; 205: 31–41.
  • 12. Mehta SR, Wood DA, Storey RF, et al; COMPLETE Trial Steering Committee and Investigators. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 2019; 381: 1411–1421.
  • 13. Redwood E, Hyun K, French JK, et al. The influence of travelling to hospital by ambulance on reperfusion time and outcomes for patients with STEMI. Med J Aust 2021; 214: 377–378.
  • 14. Farshid A, Brieger D, Hyun K, et al. Characteristics and clinical course of STEMI patients who received no reperfusion in the Australia and New Zealand SNAPSHOT ACS Registry. Heart Lung Circ 2016; 25: 132–139.
  • 15. Juergens CP, Dabin B, French JK, et al. English as a second language and outcomes of patients presenting with acute coronary syndromes: results from the CONCORDANCE registry. Med J Aust 2016; 204: 239.
  • 16. Stehli J, Duffy SJ, Burgess S, et al. Sex disparities in myocardial infarction: biology or bias? Heart Lung Circ 2021; 30: 18–26.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.